Inactive Instrument

BioNexus Gene Lab Corporation Stock Other OTC

Equities

BGLC

US0906281086

Biotechnology & Medical Research

Sales 2022 10.93M 14.9M Sales 2023 9.77M 13.32M Capitalization 9.36M 12.77M
Net income 2022 - 0 Net income 2023 -2M -2.73M EV / Sales 2022 14.9 x
Net cash position 2022 2.06M 2.81M Net cash position 2023 5.78M 7.88M EV / Sales 2023 0.37 x
P/E ratio 2022
-461 x
P/E ratio 2023
-3.2 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 35.63%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 40 23-07-31
Members of the board TitleAgeSince
Director/Board Member 68 22-03-06
Director/Board Member 48 12-10
Chief Executive Officer 40 23-07-31
More insiders
BioNexus Gene Lab Corporation is a Malaysia-based company, which provides ribonucleic acid (RNA)-based genomic diagnostics. The Company provides a molecular lab that is focused on the application of functional genomics to enable early detection of infectious diseases and cancers. The Company operates in the biochemical industry segment through its two Malaysian subsidiaries, MRNA Scientific Malaysia and Chemrex. MRNA Scientific Malaysia owns algorithm software, technology, and know-how related to the detection of common diseases through blood analysis which the Company uses in its business. The Company's non-invasive blood screening tests analyze changes in RNA to coronavirus, dengue, human immunodeficiency virus (HIV), human papillomavirus (HPV) and the risk potentiality of cancer diseases. Chemrex is a wholesaler of industrial chemicals for the manufacture of industrial, medical, appliance, aero, automotive, mechanical and electronic industries in Asean region.
More about the company